Back
Catalyst Pharmaceuticals Vs. EPAM Systems Industry Stock Comparison
Sell
49
CPRX
Catalyst Pharmaceuticals
Last Price:
16.17
Seasonality Move:
35.13%
Sell
25
EPAM
EPAM Systems
Last Price:
177.96
Seasonality Move:
11.59%
Sell
49
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $16.18. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy, Sell or Hold?
- The current EPAM Systems [EPAM] share price is $177.93. The Score for EPAM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- EPAM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $16.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
EPAM Stock Price Chart
What is EPAM Systems's stock price today?
-
The EPAM Systems share price today is $177.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 53.12 | Buy |
| Chaikin Money Flow: | -169882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.13 - 16.47) | Buy |
| Bollinger Bands (100): | (14.29 - 16.23) | Buy |
EPAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -17.28 | Sell |
| Relative Strength Index (14 RSI): | 25.93 | Sell |
| Chaikin Money Flow: | 534631 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (177.66 - 232.9) | Sell |
| Bollinger Bands (100): | (224.3 - 306.32) | Sell |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.15 | Buy |
| 20-day SMA: | 15.98 | Buy |
| 50-day SMA: | 15.66 | Buy |
| 200-day SMA: | 14.45 | Buy |
| 8-day EMA: | 16.15 | Buy |
| 20-day EMA: | 16 | Buy |
| 50-day EMA: | 15.71 | Buy |
| 200-day EMA: | 14.86 | Buy |
EPAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 182.17 | Sell |
| 20-day SMA: | 197.33 | Sell |
| 50-day SMA: | 233.53 | Sell |
| 200-day SMA: | 260.79 | Sell |
| 8-day EMA: | 181.89 | Sell |
| 20-day EMA: | 196.5 | Sell |
| 50-day EMA: | 225.81 | Sell |
| 200-day EMA: | 259.81 | Sell |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
EPAM Systems Earnings Growth & EPAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.24 per share, and an increase next year of $0.99 per share.
Catalyst Pharmaceuticals Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EPAM Systems Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||